Cardinal Health Completes Purchase of Cordis

Dublin, Ohio-based Cardinal Health has completed its $1.944 billion acquisition of Johnson & Johnson’s Cordis business, a provider of cardiology and endovascular devices.

The acquisition diversifies Cardinal’s portfolio of physician preference items, including products in the cardiovascular, wound management and orthopedics fields.

Don Casey, Cardinal’s medical segment CEO, says the combined skills and expertise of Cardinal and Cordis have created a world-class technical, clinical and commercial talent base in cardiovascular solutions.

Integration work and transitions are expected to be completed over the next few years. — Michael Cipriano